GDUFA Research Outcomes
Mixture APIs
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to complex active pharmaceutical ingredients that are comprised of a mixtures (e.g., polymers) in generic products.
-
Considerations in Developing Generic Peptide and Oligonucleotide Drug Products
Zhang, Deyi
-
Characterization and Comparative Evaluation Strategies to Demonstrate Complex API Sameness
Zhang, Deyi
-
Considerations in Demonstrating Complex API Sameness
Zhang, Deyi
-
Demonstrating Complex API Sameness
Zhang, Deyi
-
Scientific Considerations in Submitting Synthetic Peptide Drug Products as ANDAs Referencing Peptide Drug products of rDNA origin
Zhang, Deyi
-
Developing a Statistical Approach to Facilitate Sameness Assessment of Complex Heterogenous Active Pharmaceutical Ingredients
Weng, Yu Ting; Hu, Meng; Zhao, Liang; Wang, Chao; Shen, Meiyu; Gong, Xiajing
-
Identification and Quantitation of Host Cell Protein Impurities in Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry
Wang, Xiaoshi
-
Scientific Considerations for the Assessment Immunogenicity Risk of Generic Synthetic Peptide Products
Verthelyi, Daniela
-
In Vitro Binding Studies for Bioequivalence Demonstration
Sun, Wei-Jhe
-
Comparative Characterization of Highly Heterogeneous Drugs
Sasisekharan, Ram